Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease
Clinical trial NCT06314698 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06314698
- Sponsor
- RenJi Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2024-12-31
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.